Advertisement
Screener

TriSalus Life Sciences, Inc. (TLSI) Income Tax Expense

2.4 / 5 stars · 19/39 Roast Me

TriSalus Life Sciences, Inc. Income Tax Expense

TriSalus Life Sciences, Inc. (TLSI) reported Income Tax Expense of $4.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-06

  • TriSalus Life Sciences, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $4.00K.
  • TriSalus Life Sciences, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $4.00K, a 20.00% decline year-over-year.
  • TriSalus Life Sciences, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was $0.00.
  • TriSalus Life Sciences, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $5.00K.
  • TriSalus Life Sciences, Inc. income tax expense (benefit) for fiscal 2025 was $7.00K, a 16.67% increase from fiscal 2024.
  • TriSalus Life Sciences, Inc. income tax expense (benefit) for fiscal 2024 was $6.00K, a 33.33% decline from fiscal 2023.
  • TriSalus Life Sciences, Inc. income tax expense (benefit) for fiscal 2023 was $9.00K, a 0.00% change from fiscal 2022.
  • TriSalus Life Sciences, Inc. income tax expense (benefit) for fiscal 2022 was $9.00K.
Period endIncome Tax Expense (Benefit) 3 monthIncome Tax Expense (Benefit) 3 month as first filedIncome Tax Expense (Benefit) 4 monthIncome Tax Expense (Benefit) 6 monthIncome Tax Expense (Benefit) 6 month as first filedIncome Tax Expense (Benefit) 9 monthIncome Tax Expense (Benefit) 9 month as first filedIncome Tax Expense (Benefit) 12 monthIncome Tax Expense (Benefit) 12 month as first filed
2026-06-30$4.00K
10-Q · filed 2026-08-06
$8.00K
10-Q · filed 2026-08-06
$8.00K
derived: sum of 3 quarters · filed 2026-08-06
$13.00K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$4.00K
10-Q · filed 2026-05-12
$4.00K
derived: sum of 2 quarters · filed 2026-05-12
$9.00K
derived: sum of 3 quarters · filed 2026-05-12
$6.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$5.00K
derived: sum of 2 quarters · filed 2026-03-05
$2.00K
derived: sum of 3 quarters · filed 2026-08-06
$7.00K
10-K · filed 2026-03-05
2025-09-30$5.00K
10-Q · filed 2025-11-13
$2.00K
derived: sum of 2 quarters · filed 2026-08-06
$7.00K
10-Q · filed 2025-11-13
$6.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$3.00K
10-Q · filed 2026-08-06
$2.00K
10-Q · filed 2026-08-06
$1.00K
derived: sum of 3 quarters · filed 2026-08-06
-$2.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$5.00K
10-Q · filed 2026-05-12
$4.00K
derived: sum of 2 quarters · filed 2026-05-12
$1.00K
derived: sum of 3 quarters · filed 2026-05-12
$8.00K
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
-$4.00K
derived: sum of 2 quarters · filed 2026-03-05
$3.00K
derived: sum of 3 quarters · filed 2026-03-05
$6.00K
10-K · filed 2026-03-05
2024-09-30-$3.00K
10-Q · filed 2025-11-13
$4.00K
derived: sum of 2 quarters · filed 2025-11-13
$7.00K
10-Q · filed 2025-11-13
$8.00K
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$7.00K
10-Q · filed 2025-08-12
$10.00K
10-Q · filed 2025-08-12
$11.00K
derived: sum of 3 quarters · filed 2025-08-12
$11.00K
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$3.00K
10-Q · filed 2025-05-15
$4.00K
derived: sum of 2 quarters · filed 2025-05-30
$4.00K
derived: sum of 3 quarters · filed 2025-05-30
$17.00K
derived: sum of 4 quarters · filed 2025-05-30
2023-12-31$1.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-05-30
$1.00K
derived: sum of 2 quarters · filed 2025-05-30
$14.00K
derived: sum of 3 quarters · filed 2025-05-30
$9.00K
10-K/A · filed 2025-05-30
2023-09-30$0.00
10-Q · filed 2024-11-14
$13.00K
derived: sum of 2 quarters · filed 2024-11-14
$8.00K
10-Q · filed 2024-11-14
$14.00K
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$13.00K
10-Q · filed 2024-08-14
$42.72K
10-Q · filed 2023-08-02
$8.00K
10-Q · filed 2024-08-14
$69.84K
10-Q · filed 2023-08-02
$14.00K
derived: sum of 3 quarters · filed 2024-08-14
$14.00K
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$5.00K
10-Q · filed 2024-05-15
$27.12K
10-Q · filed 2023-05-12
$1.00K
derived: sum of 2 quarters · filed 2024-05-15
$1.00K
derived: sum of 3 quarters · filed 2024-05-15
$29.20K
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$6.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-11
$6.00K
derived: sum of 2 quarters · filed 2024-04-11
$34.20K
derived: sum of 3 quarters · filed 2024-04-11
$9.00K
10-K · filed 2024-04-11
$570.85K
10-K · filed 2023-03-22
2022-09-30$0.00
10-Q · filed 2023-11-14
$191.28K
10-Q · filed 2022-11-10
$28.20K
derived: sum of 2 quarters · filed 2023-11-14
$3.00K
10-Q · filed 2023-11-14
$219.49K
10-Q · filed 2022-11-10
$28.20K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$28.20K
10-Q · filed 2023-08-02
$28.20K
10-Q · filed 2023-08-02
$28.20K
derived: sum of 3 quarters · filed 2023-08-02
$28.20K
derived: sum of 4 quarters · filed 2023-08-02
2022-03-31$0.00
10-Q · filed 2022-05-11
$0.00
derived: sum of 2 quarters · filed 2023-03-22
$0.00
derived: sum of 3 quarters · filed 2023-03-22
$0.00
derived: sum of 4 quarters · filed 2023-03-22
2021-12-31$0.00
derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-22
$0.00
derived: sum of 2 quarters · filed 2023-03-22
$0.00
derived: sum of 3 quarters · filed 2023-03-22
$0.00
10-K · filed 2023-03-22
2021-09-30$0.00
10-Q/A · filed 2021-12-13
$0.00
derived: sum of 2 quarters · filed 2021-12-13
$0.00
10-Q/A · filed 2021-12-13
2021-06-30$0.00
10-Q · filed 2021-08-16
$0.00
10-Q · filed 2021-08-16
2021-03-31$0.00
10-Q · filed 2022-05-11
2020-12-31$0.00
10-K · filed 2022-03-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cytosorbents Corp (CTSO)United States$0.274B-1.29
Mobia Medical, Inc. (MOBI)United States$0.293B
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Embecta Corp. (EMBC)United States$0.319B2.10
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
PRO DEX INC (PDEX)United States$0.234B13.64
Neuronetics, Inc. (STIM)United States$0.216B-3.25